Markets › United States › NAS › CAPR

Capricor Therapeutics Inc

NAS:CAPRHealthcareCBOEFTSE:MRUTNASDAQ:NQUSSG

$6.64−0.23%LiveIn session · ≈ AED 24.37 · Market cap $385.75M · Next earnings Mon 9 Nov

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	100.0%	100.0%	−755.1%	−44.8%	−124.4%	—	—	—
Operating margin	−4,412.6%	−8,549.9%	−1,163.9%	−95.6%	−191.1%	—	—	—
Net margin	−4,401.9%	−8,175.9%	−1,137.4%	−88.5%	−181.7%	—	—	—
EBITDA margin	−4,366.2%	−8,075.5%	−1,116.5%	−84.3%	−175.3%	—	—	—
Return on equity	−48.4%	−63.8%	−246.2%	−98.6%	−27.8%	−34.4%	−34.4%	+0.0 pts
Return on assets	−39.4%	−48.4%	−57.9%	−37.9%	−23.7%	−29.5%	−29.5%	+0.0 pts
Return on capital employed	−43.3%	−56.3%	−112.0%	−87.7%	−28.5%	−33.8%	—	—
Debt / equity	0.1×	0.2×	0.5×	0.2×	0.0×	0.1×	0.1×	+0.0%
Debt / assets	10.7%	15.1%	11.9%	9.6%	2.8%	5.0%	—	—
Interest coverage	0.0×	0.0×	0.0×	0.0×	0.0×	−35.5×	—	—
Current ratio	11.3×	8.8×	1.8×	1.6×	7.8×	9.0×	9.0×	+0.0%
Quick ratio	11.3×	8.8×	1.8×	1.6×	7.8×	9.0×	—	—
Cash ratio	11.0×	8.4×	0.4×	0.5×	0.5×	8.0×	8.0×	+0.0%
Asset turnover	0.0×	0.0×	0.1×	0.4×	0.1×	0.0×	—	—
Receivables turnover	5.5×	0.6×	4.7×	2.4×	2.1×	0.0×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—